skin cancer

Roche’s Zelboraf Fails To Win U.K. Drug-Cost Agency Backing

Roche’s Zelboraf Fails To Win U.K. Drug-Cost Agency Backing

Bloomberg

Roche Drug Reduces Skin Growths In Gene-Mutation Patients

Roche Drug Reduces Skin Growths In Gene-Mutation Patients

Bloomberg

Bristol Immune Drug Success In Cancer May Spur Industry Race

Bristol Immune Drug Success In Cancer May Spur Industry Race

Bloomberg

Bristol-Myers Immune Drug Puts Deadly Cancers on Hold in Study

Bristol-Myers Immune Drug Puts Deadly Cancers on Hold in Study

Bloomberg

How OncoSec Opens Up Skin Cancer Cells To Drugs

How OncoSec Opens Up Skin Cancer Cells To Drugs

Seeking Alpha

FDA Approves Roche, Curis Skin-Cancer Drug

FDA Approves Roche, Curis Skin-Cancer Drug

TheStreet.com

Roche’s Zelboraf for Melanoma Spurs Other Skin Cancer’s Growth, Study Says

Roche’s Zelboraf for Melanoma Spurs Other Skin Cancer’s Growth, Study Says

Bloomberg

Chronic Bowel Disease Drugs Linked to Skin Cancer Risk

Chronic Bowel Disease Drugs Linked to Skin Cancer Risk

Yahoo/Health Day

FDA gives priority to Roche skin cancer drug vismodegib

FDA gives priority to Roche skin cancer drug vismodegib

Pharma Times, UK